Ftse Mib
37.582,05
0,00%
DAX
22.034,13
0,00%
S&P 500
6.068,50
0,03%
NASDAQ
19.643,86
-0,36%
Bitcoin
96.112,72
0,38%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE West Pharmaceutical Services Inc (WST) West Pharmaceutical Services Inc (WST) Notizie

WST

West Pharmaceutical Serv... (WST)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:WST
DataOraFonteTitoloSimboloCompagnia
30/01/202512:00PR Newswire (US)West to Host Fourth-Quarter and Full-Year 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
28/01/202518:00PR Newswire (US)West Announces First-Quarter DividendNYSE:WSTWest Pharmaceutical Services Inc
22/01/202512:00PR Newswire (US)West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at PharmapackNYSE:WSTWest Pharmaceutical Services Inc
17/01/202519:27Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
17/01/202519:23Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
06/01/202522:30PR Newswire (US)West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
19/12/202400:34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
19/12/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
13/12/202422:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:WSTWest Pharmaceutical Services Inc
11/12/202412:00PR Newswire (US)West Elects New Director to the BoardNYSE:WSTWest Pharmaceutical Services Inc
29/10/202411:00PR Newswire (US)West to Participate in Upcoming Investor ConferencesNYSE:WSTWest Pharmaceutical Services Inc
24/10/202422:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:WSTWest Pharmaceutical Services Inc
24/10/202412:00PR Newswire (US)West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
23/10/202422:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:WSTWest Pharmaceutical Services Inc
22/10/202412:00PR Newswire (US)West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA ConferenceNYSE:WSTWest Pharmaceutical Services Inc
10/10/202412:00PR Newswire (US)West to Host Third-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
09/10/202412:00PR Newswire (US)West Wins Heart of Pharma Award at 2024 CPHI Pharma AwardsNYSE:WSTWest Pharmaceutical Services Inc
07/10/202412:00PR Newswire (US)West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide ConferenceNYSE:WSTWest Pharmaceutical Services Inc
05/09/202412:00PR Newswire (US)West to Participate in Upcoming Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
06/08/202422:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
25/07/202412:00PR Newswire (US)West Announces Second-Quarter 2024 ResultsNYSE:WSTWest Pharmaceutical Services Inc
11/07/202412:00PR Newswire (US)West to Host Second-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
29/05/202412:00PR Newswire (US)West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene TherapyNYSE:WSTWest Pharmaceutical Services Inc
22/05/202422:05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:WSTWest Pharmaceutical Services Inc
25/04/202412:00PR Newswire (US)West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
11/04/202412:00PR Newswire (US)West to Host First-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
01/03/202422:24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:WSTWest Pharmaceutical Services Inc
20/02/202422:44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:WSTWest Pharmaceutical Services Inc
20/02/202412:00PR Newswire (US)West Announces Second-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
15/02/202412:00PR Newswire (US)West Announces Fourth-Quarter and Full-Year 2023 ResultsNYSE:WSTWest Pharmaceutical Services Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:WST

La tua Cronologia

BIT
11COV
Bearer
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci